Literature DB >> 28253718

TNFAIP3 inhibits migration and invasion in nasopharyngeal carcinoma by suppressing epithelial mesenchymal transition.

T Huang, L Yin, J Wu, J J Gu, K Ding, N Zhang, M Y Du, L X Qian, Z W Lu, X He.   

Abstract

TNF alpha induced protein 3 (TNFAIP3), a member of zinc finger protein family, is a gene whose expression level is promptly induced by the tumor necrosis factor. In this study, the clinical significance of TNFAIP3 was analyzed based on available samples in The Cancer Genome Atlas database. TNFAIP3 downregulation was associated with distant metastasis and worse patient prognosis. TNFAIP3-overexpressing and TNFAIP3-knockdown NPC cell line models were established through plasmid-mediated overexpression and small interfering RNA (siRNA), respectively. Cell migration and invasion capacities were evaluated by wound-healing and transwell assays. Functional studies indicated that TNFAIP3 knockdown promoted migration and invasion, whereas TNFAIP3 overexpression alleviated these functions. Western blot analysis was used to examine protein changes from TNFAIP3 overexpression and knockdown, in which TNFAIP3 promoted the protein expression of E-cadherin and suppressed vimentin expression. Our data suggested that TNFAIP3 inhibited migration and invasion by suppressing epithelial mesenchymal transition in NPC.

Entities:  

Keywords:  TNFAIP3; invasion metastasis.; nasopharyngeal carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28253718     DOI: 10.4149/neo_2017_309

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  8 in total

1.  Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response.

Authors:  Elizabeth A Mazzio; Charles A Lewis; Rashid Elhag; Karam F Soliman
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 3.395

2.  TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.

Authors:  Mao Yang; Xiaobin Yu; Xuesen Li; Bo Luo; Wenli Yang; Yan Lin; Dabing Li; Zhonglin Gan; Jianming Xu; Tao He
Journal:  Breast Cancer Res       Date:  2018-08-15       Impact factor: 6.466

3.  Differential Expression and Alternative Splicing of Transcripts Associated With Cisplatin-Induced Chemoresistance in Nasopharyngeal Carcinoma.

Authors:  Jian Zhang; Huali Jiang; Tao Xie; Jieling Zheng; Yunhong Tian; Rong Li; Baiyao Wang; Jie Lin; Anan Xu; Xiaoting Huang; Yawei Yuan
Journal:  Front Genet       Date:  2020-02-25       Impact factor: 4.599

Review 4.  Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer.

Authors:  Seung Wan Son; Mun Gyu Song; Ba Da Yun; Jong Kook Park
Journal:  Biomedicines       Date:  2021-03-07

5.  Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes.

Authors:  Xiaoqiong He; Qian Yao; Dan Fan; Yutong You; Wenjing Lian; Zhangping Zhou; Ling Duan
Journal:  Discov Oncol       Date:  2022-08-19

6.  Ferroptosis regulators related scoring system by Gaussian finite mixture model to predict prognosis and immunotherapy efficacy in nasopharyngeal carcinoma.

Authors:  Zijian Liu; Jinlan He; Xiaolin Hu
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

Review 7.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23

8.  Comprehensive analysis of the expression and prognosis for TNFAIPs in head and neck cancer.

Authors:  Gaochen Lan; Xiaoling Yu; Xin Sun; Wan Li; Yanna Zhao; Jinjian Lan; Xiaolong Wu; Ruilan Gao
Journal:  Sci Rep       Date:  2021-08-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.